{"url_path":"/fda/drug/recalls/D-0541-2026","section_key":"summary","section_title":"DRUG Recall: Lupin Pharmaceuticals Inc. — Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-24","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0541-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Lupin Pharmaceuticals Inc."},"word_count":111,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0541-2026\n\n**Recalling firm:** Lupin Pharmaceuticals Inc.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-24\n**Report date:** 2026-05-27\n\n## Product\nLiraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.\n\n## Reason\nPresence of particulate matter: a white thread-like structure in the cartridge\n\n## Affected lots\nLots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.\n\n## Distribution\nNationwide within U.S"}